Wolters Kluwer Health announced on November 13, 2026, that it had signed an agreement to acquire AgileMD for up to $100 million, a transaction that would add interactive clinical pathways and AI-powered patient-deterioration surveillance to its clinical business. The consideration consists of a $40 million upfront payment and a deferred balance contingent on performance targets. The transaction is expected to close in the first quarter of 2027 or sooner, subject to customary closing conditions…
This article has been indexed from Unite.AI
Read the original article: